One of the elements of feedback that we've given to Congress through our technical assistance is to make sure that the patient protections that Congress intended to be available un...
the Commissioner of the Food and Drug Administration should clearly communicate how the agency will use adverse event data from expanded acc...
the Right to Try laws address none of those reasons, and I think that is--in my original statement, I said this is feel-good legislation for...
The argument that Right to Try legislation is going to make more people have access to experimental medicines does not exist in my mind as a...
While I appreciate the intent of the legislation, I cannot support it in its current form.
I hear from patients with serious life-threatening conditions, constituents in north Texas, being frustrated with what they see as a regulat...
Today the DCCP subcommittee will focus on a massive data breach executed against Equifax, but this is just one of many recent data breaches ...
I shared Mr. Engel's concern that we finish up our work and both houses get the work done and get the programs approved.
addressing the elder care workforce crisis and the other vital health professions programs under the Public Health Service Act is an opportu...
I have always found that door to be open, and I have been grateful for that.
I made the decision nothing was going to deter us from getting the user-fee agreements across the finish line.